Previous 10 | Next 10 |
China Pharma's Candesartan Hypertension Product Passes the Quality and Efficacy Consistency Evaluation of Generic Drugs PR Newswire HAIKOU, China , Aug. 9, 2023 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "W...
China Pharma ( NYSE: CPHI ) on Friday said it expects to implement a 1-for-10 reverse stock split on its common stock. Trading to begin on a split-adjusted basis at market open on March 6, 2023. Trading in the common stock will continue on the NYSE American under...
China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock Split PR Newswire HAIKOU, China , Feb. 24, 2023 /PRNewswire/ -- China Pharma Holdings Inc. ("China Pharma" or the "Company") (NYSE American: CPHI) reported that it expects to implement a 1-f...
China Pharma Holdings, Inc. Announced the Launch of N95 Medical Protective Mask PR Newswire HAIKOU, China , Dec. 28, 2022 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma", the "Company" or "We"), an NYSE American-listed corpor...
China Pharma Holdings, Inc. Announced that several products are included in the Catalogue of Medicines for People Infected with COVID-19 PR Newswire HAIKOU, China , Dec. 15, 2022 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma...
China Pharma Holdings, Inc. Announced the Acquisition of Dry Eye Disease Therapeutic Device Project PR Newswire HAIKOU, China , Dec. 5, 2022 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma", the "Company" or "We"), an NYSE Ame...
China Pharma ( NYSE: CPHI ) received a deficiency letter from NYSE stating that the company's common stock has been selling for a low price per share for a substantial period of time. Most recently, the average price of the company's common stock had been below $0.20 on a ...
China Pharma Announces Receipt of Notification of NYSE American Listing Deficiency PR Newswire HAIKOU, China , Oct. 1, 2022 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI; the "Company") today announced that on September 26, 2022 ...
China Pharma ( NYSE: CPHI ) said it submitted a plan of compliance to the NYSE American to address a deficiency in the company's stockholders' equity. In June, the company received a letter from the exchange noting that it was not in compliance with continued listi...
China Pharma Announced the Submission of a Plan of Compliance to NYSE American PR Newswire HAIKOU, China , July 18, 2022 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceuti...
News, Short Squeeze, Breakout and More Instantly...
China Pharma Holdings Inc. Company Name:
CPHI Stock Symbol:
NYSE Market:
China Pharma Holdings Inc. Website:
A look at the top 10 most actives in the United States Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 6.8% to $3.17 on volume of 217,637,164 shares Palantir Technologies Inc. Class A (PLTR) rose 9.9% to $26.16 on volume of 207,386,942 shares PROSHARES TRUST (SQQQ) fell 1.9% to $1...
A look at the top 10 most actives in the United States Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 5.9% to $3.1999 on volume of 196,096,419 shares Palantir Technologies Inc. Class A (PLTR) rose 9.8% to $26.14 on volume of 179,511,914 shares WiSA Technologies Inc. (WISA) fell 1...